FDA Inspection 1121884 — Dompe Farmaceutici S.p.A.
The FDA completed an inspection of Dompe Farmaceutici S.p.A. on January 30, 2020 in L'Aquila. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Drugs.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- January 30, 2020
- Fiscal Year
- 2020
- Product Type
- Drugs
- Project Area
- Drug Quality Assurance
- Location
- L'Aquila (Italy)